Product How it works Pricing Blog FAQ About Contact
Pro-DEX

Pro-DEX (NASDAQ: PDEX) revenue

Pro-DEX reported revenue of $77.5m for fiscal 2026, 16.5% more than in fiscal 2025 ($66.6m). Since fiscal 2017 its revenue has grown by 253.4%, an average growth of 15.1% a year.

Pro-DEX has grown its revenue for 9 years in a row, and fiscal 2026 is the highest of its 10 fiscal years on record.

Revenue, in millions of US dollars21.9201722.5201827.2201934.8202038.0202142.0202246.1202353.8202466.6202577.52026
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2026$77.5m+16.5%$13.0m16.8%
2025$66.6m+23.7%$10.7m16.1%
2024$53.8m+16.8%$7.2m13.3%
2023$46.1m+9.6%$5.8m12.5%
2022$42.0m+10.5%$5.1m12.2%
2021$38.0m+9.2%$4.5m11.9%
2020$34.8m+28.2%$7.1m20.3%
2019$27.2m+21.0%$5.0m18.4%
2018$22.5m+2.4%$2.4m10.6%
2017$21.9m—$2.7m12.5%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Pro-DEX revenue compared with its sector

By revenue for its latest fiscal year, Pro-DEX ranks 304th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Pro-DEX, 16.5%.

RankCompanyRevenueRevenue growth
302ndETON Pharmaceuticals$80.0m104.9%
303rdSimulations Plus$79.2m13.1%
304thPro-DEX$77.5m16.5%
305thSight Sciences$77.4m−3.1%
306thCytomX Therapeutics$76.2m−44.8%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Pro-DEX

How much revenue did Pro-DEX make in fiscal 2026?
Pro-DEX reported revenue of $77.5m for fiscal 2026, compared with $66.6m in fiscal 2025.
How much has the revenue of Pro-DEX grown?
Between fiscal 2017 and fiscal 2026 it went from $21.9m to $77.5m: 253.4% more, an average growth of 15.1% a year.
What was the best year for revenue at Pro-DEX?
Of its last 10 fiscal years, fiscal 2026, with $77.5m.
Where does Pro-DEX rank in its sector by revenue?
It ranks 304th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Pro-DEX come from?
From the annual report (Form 10-K) that Pro-DEX files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Pro-DEX files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Pro-DEX: the Pro-DEX page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.